Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells 500 Shares of Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 500 shares of the company’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $29.68, for a total value of $14,840.00. Following the completion of the transaction, the senior vice president now owns 230,771 shares in the company, valued at $6,849,283.28. This represents a 0.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

David Linetsky also recently made the following trade(s):

• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $321,103.80.
• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $25.38, for a total value of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The stock was sold at an average price of $24.88, for a total value of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The shares were sold at an average price of $24.85, for a total value of $294,547.05.

Phreesia Stock Down 1.8 %

PHR traded down $0.53 during trading on Friday, hitting $28.47. 306,682 shares of the company’s stock traded hands, compared to its average volume of 388,179. The company’s 50 day simple moving average is $24.98 and its two-hundred day simple moving average is $23.28. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $29.90. The stock has a market capitalization of $1.65 billion, a price-to-earnings ratio of -19.37 and a beta of 0.94.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period last year, the business posted ($0.58) EPS. Analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on PHR shares. Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Robert W. Baird dropped their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. KeyCorp increased their target price on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research report on Wednesday. Thirteen research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $31.15.

Hedge Funds Weigh In On Phreesia

A number of institutional investors and hedge funds have recently modified their holdings of the company. Trust Point Inc. lifted its position in Phreesia by 3.5% during the third quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock valued at $408,000 after purchasing an additional 607 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of Phreesia by 3.3% in the third quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock worth $637,000 after purchasing an additional 905 shares during the last quarter. MetLife Investment Management LLC increased its holdings in shares of Phreesia by 3.8% in the third quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock worth $701,000 after purchasing an additional 1,120 shares during the last quarter. R Squared Ltd bought a new stake in shares of Phreesia in the fourth quarter worth about $30,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in Phreesia by 9.9% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,015 shares of the company’s stock worth $319,000 after acquiring an additional 1,258 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.